Probiotics in septic acute kidney injury, a double blind, randomized control trial

Simple item page
dc.contributor.authorJonathan S. Chávez-Íñiguez
dc.contributor.authorMiguel Ibarra‐Estrada
dc.contributor.authorAlejandro Martínez Gallardo-González
dc.contributor.authorAri Cisneros-Hernández
dc.contributor.authorRolando Claure‐Del Granado
dc.contributor.authorGael Chávez-Alonso
dc.contributor.authorEduardo M. Hernández-Barajas
dc.contributor.authorAlexia C. Romero-Muñoz
dc.contributor.authorFidel Ramos-Avellaneda
dc.contributor.authorManuel Luis Prieto-Magallanes
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:20:25Z
dc.date.available2026-03-22T14:20:25Z
dc.date.issued2023
dc.descriptionCitaciones: 12
dc.description.abstractIn AKI related to sepsis, probiotics for 7 consecutive days did not increase the probability of KFR, nor did other variables related to clinical improvement, although they were safe.
dc.identifier.doi10.1080/0886022x.2023.2260003
dc.identifier.urihttps://doi.org/10.1080/0886022x.2023.2260003
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45938
dc.language.isoen
dc.publisherTaylor & Francis
dc.relation.ispartofRenal Failure
dc.sourceHospital Civil de Guadalajara
dc.subjectMedicine
dc.subjectAcute kidney injury
dc.subjectSepsis
dc.subjectPlacebo
dc.subjectInternal medicine
dc.subjectAdverse effect
dc.subjectRandomized controlled trial
dc.subjectGastroenterology
dc.subjectUrinary system
dc.subjectProbiotic
dc.titleProbiotics in septic acute kidney injury, a double blind, randomized control trial
dc.typearticle

Files

Collections

Artículo Científico Publicado